AnalystsInsight

Faisal Khurshid (Jefferies): Analyst Track Record and Price‑Target Accuracy

How often Faisal Khurshid’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 407 ratings, compared with the average Wall Street analyst.

Published Updated 3 min readHow we research

Key takeaways

  • Faisal Khurshid ranks #103 of 1,000 analysts in Exent’s scoring (5.0★).
  • 46.8% of price targets were reached over 7 years, versus 52.4% for the average analyst.
  • Median time to reach a target: 134 days; 54.0% of calls were up 12 months later.
  • Most‑covered stocks: ATYR, ANIP, KYMR, PLRX.

Faisal Khurshid’s track record at a glance

Faisal Khurshid of Jefferies ranks #103 of the 1,000 analysts Exent scores, with a 5.0★ rating and a focus on healthcare. Over a 7‑year lookback, 46.8% of Faisal’s price targets were reached, 5.6 points below the 52.4% average across all analysts.

MetricFaisal KhurshidAll analysts
Price‑target hit rate46.8%52.4%
Median days to hit target134 days91 days
Calls up after 12 months54.0%64.0%
Median 12‑month return of calls+11.1%+13.4%
Hit rate, last 2 years46.8%—
Average worst drop after a call−34.8%—
Ratings in the sample407—
Stocks covered38—

How fast price targets were reached

Time to reach the targetFaisal Khurshid
Under 30 days25.7%
30–90 days12.9%
90–180 days25.7%
Over 180 days35.7%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Faisal Khurshid covers most

StockRatings in the sample
ATYR36
ANIP27
KYMR25
PLRX23
TRVI21
SYRE20
RYTM18
NRIX18

In the past year Faisal’s ratings were 72% Buy, 28% Hold and 0% Sell.

Recent ratings (shown with a 30-day delay)

DateStockActionRatingPrice target
Sep 9, 2026SMMTUpgraded: BuyBuy$25.00
Sep 8, 2026ALNYReiterated: HoldHold$260.00
Sep 3, 2026RVMDReiterated: BuyBuy$270.00
Aug 31, 2026ASNDReiterated: BuyBuy$330.00
Aug 28, 2026ALNYReiterated: HoldHold$230.00
Aug 27, 2026RVMDReiterated: BuyBuy$270.00
Aug 25, 2026IMTXRated: BuyBuy$17.00
Aug 17, 2026EYPTReiterated: BuyBuy$8.00
Aug 6, 2026INSMReiterated: BuyBuy$175.00
Jul 31, 2026GLUEReiterated: BuyBuy$25.00
Jul 31, 2026ALNYReiterated: HoldHold$230.00
Jul 24, 2026SMMTReiterated: HoldHold$15.00
  • Sep 9, 2026
    Stock
    SMMT
    Action
    Upgraded: Buy
    Rating
    Buy
    Price target
    $25.00
  • Sep 8, 2026
    Stock
    ALNY
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $260.00
  • Sep 3, 2026
    Stock
    RVMD
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $270.00
  • Aug 31, 2026
    Stock
    ASND
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $330.00
  • Aug 28, 2026
    Stock
    ALNY
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $230.00
  • Aug 27, 2026
    Stock
    RVMD
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $270.00
  • Aug 25, 2026
    Stock
    IMTX
    Action
    Rated: Buy
    Rating
    Buy
    Price target
    $17.00
  • Aug 17, 2026
    Stock
    EYPT
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $8.00
  • Aug 6, 2026
    Stock
    INSM
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $175.00
  • Jul 31, 2026
    Stock
    GLUE
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $25.00
  • Jul 31, 2026
    Stock
    ALNY
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $230.00
  • Jul 24, 2026
    Stock
    SMMT
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $15.00

Live ratings from Faisal Khurshid and the other top‑ranked analysts, and the stocks where they agree, are in Exent Stocks Radar.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 19, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Stocks Radar shows Faisal Khurshid’s live ratings and those of the other top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Faisal Khurshid ranks #103 of 1,000 with a 5.0★ rating. 46.8% of price targets were reached over a 7-year lookback (all analysts: 52.4%), and 54.0% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

Faisal Khurshid’s success rate is 58.3% by the ranking source and 46.8% by Exent’s price-target hit-rate backtest, with a median of 134 days to reach a target.

Faisal Khurshid (Jefferies) covers 38 stocks, mostly in healthcare. The most frequently rated are ATYR, ANIP, KYMR, PLRX, TRVI.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.